GGrantIndex
Sort

8,912 grants matching sars cov 2

The evolutionary genetic basis for changes in viral receptor-binding specificities

$41,963
Caroline Craig · Utah State Higher Education System--University Of Utah · F31 · FY2025 · AI

Elucidating the Roles of the Membrane-Binding Proteins ciBAR1 and ciBAR2 in Ciliogenesis

$41,904
Eunice Na Young Kim · State University New York Stony Brook · F31 · FY2025 · HL

Viral Oral Infections in Immunosuppression and Cancer Section

$41,866
William Seaman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Impacts of SARS-CoV-2 Infection and Age on Musculoskeletal Health

$41,715
Olatundun Dupe Awosanya · Indiana University Indianapolis · F31 · FY2024 · AG

NK killing of coronavirus-infected cells

$41,677
Mercedes Lewandrowski · Harvard Medical School · F31 · FY2023 · AI

An Analysis Of The Multi-Level Factors That Impact Provision Of Emergency Medical Services To Hispanic Older Adults

$41,469
Esmeralda Melgoza · University Of California Los Angeles · R36 · FY2024 · AG

Elucidating the Roles of the Membrane-Binding Proteins ciBAR1 and ciBAR2 in Ciliogenesis

$41,340
Eunice Na Young Kim · State University New York Stony Brook · F31 · FY2024 · HL

Targeting SARS-CoV-2 PLpro for COVID-19 treatment

$41,147
Rui Xiong · University Of Illinois At Chicago · R01 · FY2022 · AI

Investigation of the therapeutic potential of oxysterols in SARS-CoV-2 infection

$40,758
Michael B Fessler · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES

Inhaled Vitamin D as a Protectant Against Respiratory Infections and Environmental Pollutants

$40,752
Kevin David Schichlein · Univ Of North Carolina Chapel Hill · F31 · FY2025 · HL

Serologic studies of persons with COVID-19 infection

$40,704
Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Defining the role of natural killer cells in COVID-19

$40,696
Madeline Jane Lee · Stanford University · F31 · FY2023 · AI

Clinical Studies Core

$40,643
Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2025 · AI

Implementation and Evaluation of Two SARS-CoV-2 Assays for Companion Animal Testing to Expand Vet-LIRN COVID-19 Capacity

$40,625
Stephen Douglas Cole · University Of Pennsylvania · U18 · FY2023 · FD

Determining Tropism and Mechanisms of Ebola Virus Entry in Placental Tissues

$40,604
Hanora Anne Marie Van Ert · University Of Iowa · F30 · FY2024 · AI

Chemosensation and COVID-19

$40,457
Paule Joseph · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA

Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)

$40,374
Kathryn M Anastos · Albert Einstein College Of Medicine · U01 · FY2021 · HL

Frontiers in Cancer Research (SEPA Supplement)

$40,311
Jeanne Ting Chowning · Fred Hutchinson Cancer Research Center · R25 · FY2021 · GM

Investigation of the therapeutic potential of oxysterols in SARS-CoV-2 infection

$40,197
Michael B Fessler · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES

Impacts of SARS-CoV-2 Infection and Age on Musculoskeletal Health

$40,194
Olatundun Dupe Awosanya · Indiana University Indianapolis · F31 · FY2023 · AG

Development of COVID-19 cell entry inhibitors

$40,169
Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Role of SARS-CoV-2 Spike Protein and Accessory ORFs in the immune pathogenesis of COVID-19

$40,147
John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Elucidating the Roles of the Membrane-Binding Proteins ciBAR1 and ciBAR2 in Ciliogenesis

$40,060
Eunice Na Young Kim · State University New York Stony Brook · F31 · FY2023 · HL

Lung Epithelium in Health and Disease

$40,000
Jennifer Malcolmsrygley Sucre · Federation Of Amer Soc For Exper Biology · R13 · FY2024 · HL

Unraveling the Viral Infection Pathway with Virus-locked Observation

$40,000
Kevin Welsher · Duke University · R35 · FY2023 · GM